Brussels sees hantavirus as sign of more frequent, intense outbreaks and calls for greater cross‑border cooperation

Defending robust national health systems to better respond to new health crises

European Commissioner for International Partnerships, Josef Síkela, warned on Wednesday that the hantavirus outbreak on a cruise ship—forcing the disembarkation of patients from the Canary Islands—is a clear sign that disease outbreaks are becoming “more frequent and intense.” He stressed the need to move toward stronger health cooperation between EU Member States and third‑country partners to curb potential future crises.

“The hantavirus outbreak last week on a cruise in the Atlantic reminds us of our vulnerability when it comes to health,” Síkela told a press conference in Brussels, where he unveiled details of his proposed ‘road‑map’ to boost global resilience against health emergencies.

Drawing on the recent experience of the COVID‑19 pandemic, the commissioner added:

“The reality is that the frequency and intensity of disease outbreaks are increasing.”

A Nine‑Step Strategy

Brussels is advocating a nine‑step strategy aimed at reducing fragmentation in the global health architecture and improving overall effectiveness. The initiative, dubbed “Global Health Resilience,” currently lacks dedicated financing.

Key challenges highlighted include:

• Too many actors and overlapping mandates in cross‑border situations.
• The EU’s commitment to act as a coordinator among Member States for internal responses.
• A pledge to invest outside the bloc in the health sector.

The European Union has already mobilised over €6 billion for health investments under the Neighbourhood, Development and International Cooperation Instrument – Global Europe.

Pillars of the New Strategy

• Robust national health systems: Countries that can fund, manage, and deliver essential health services are better positioned to handle crises, protect their populations, and maintain continuity of care.
• Strengthening global networks: Enhancing detection and response capabilities for epidemic threats, while ensuring wider access to medicines, vaccines, and diagnostic tests in vulnerable regions.
• Diversifying supply chains: Expanding the production of critical health products to reduce reliance on single sources.
• Building societal resilience: Promoting trust in science and combating the spread of health‑related misinformation and rumors.

These measures are slated for implementation between 2026 and 2027, though a precise timetable and detailed action plan have yet to be released.